In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.

Take a closer look at EXELIXIS INC (NASDAQ:EXEL), a remarkable value stock uncovered by our stock screener. NASDAQ:EXEL excels in fundamentals and maintains a very reasonable valuation. Let's break it down further.

Analyzing Valuation Metrics

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:EXEL has achieved a 7 out of 10:

• EXEL's Price/Earnings ratio is rather cheap when compared to the industry. EXEL is cheaper than 95.29% of the companies in the same industry.
• Compared to the rest of the industry, the Price/Forward Earnings ratio of EXEL indicates a rather cheap valuation: EXEL is cheaper than 96.63% of the companies listed in the same industry.
• 95.12% of the companies in the same industry are more expensive than EXEL, based on the Enterprise Value to EBITDA ratio.
• Based on the Price/Free Cash Flow ratio, EXEL is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• EXEL has a very decent profitability rating, which may justify a higher PE ratio.
• A more expensive valuation may be justified as EXEL's earnings are expected to grow with 49.79% in the coming years.

Looking at the Profitability

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:EXEL has achieved a 7:

• With an excellent Return On Assets value of 7.06%, EXEL belongs to the best of the industry, outperforming 96.63% of the companies in the same industry.
• EXEL has a better Return On Equity (9.18%) than 95.79% of its industry peers.
• EXEL's Return On Invested Capital of 5.31% is amongst the best of the industry. EXEL outperforms 95.45% of its industry peers.
• EXEL has a Profit Margin of 11.35%. This is amongst the best in the industry. EXEL outperforms 95.96% of its industry peers.
• EXEL's Operating Margin of 9.34% is amongst the best of the industry. EXEL outperforms 95.62% of its industry peers.
• EXEL has a better Gross Margin (96.04%) than 95.96% of its industry peers.

Deciphering NASDAQ:EXEL's Health Rating

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:EXEL scores a 7 out of 10:

• An Altman-Z score of 7.15 indicates that EXEL is not in any danger for bankruptcy at the moment.
• With an excellent Altman-Z score value of 7.15, EXEL belongs to the best of the industry, outperforming 80.81% of the companies in the same industry.
• EXEL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
• EXEL has a Current Ratio of 3.34. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.
• A Quick Ratio of 3.30 indicates that EXEL has no problem at all paying its short term obligations.

Deciphering NASDAQ:EXEL's Growth Rating

To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. NASDAQ:EXEL has achieved a 5 out of 10:

• EXEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.28%, which is quite good.
• Looking at the last year, EXEL shows a quite strong growth in Revenue. The Revenue has grown by 13.60% in the last year.
• EXEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.47% yearly.
• The Earnings Per Share is expected to grow by 30.94% on average over the next years. This is a very strong growth
• When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More Decent Value stocks can be found in our Decent Value screener.

Our latest full fundamental report of EXEL contains the most current fundamental analsysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.